BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20534090)

  • 1. Co-infection of mucosal leishmaniasis and extra pulmonary tuberculosis in a patient with inherent immune deficiency.
    Rathnayake D; Ranawake RR; Sirimanna G; Siriwardhane Y; Karunaweera N; De Silva R
    Int J Dermatol; 2010 May; 49(5):549-51. PubMed ID: 20534090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chronic mutilating rhinopathy with a delayed diagnosis of mucocutaneous leishmaniasis.
    Karimbil SK; Kumari S; Celine MI; Joy A
    Int J Dermatol; 2010 Apr; 49(4):426-9. PubMed ID: 20465699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical mucocutaneous involvement with Leishmania donovani.
    Pulimood SA; Rupali P; Ajjampur SS; Thomas M; Mehrotra S; Sundar S
    Natl Med J India; 2012; 25(3):148-50. PubMed ID: 22963292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India.
    Verma SK; Ahmad S; Shirazi N; Kusum A; Kaushik RM; Barthwal SP
    Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):730-2. PubMed ID: 17382981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmaniasis.
    Evans TG
    Infect Dis Clin North Am; 1993 Sep; 7(3):527-46. PubMed ID: 8254158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral leishmaniasis: a rare cause of post-transplant fever and pancytopenia.
    Rajaram KG; Sud K; Kohli HS; Gupta KL; Sakhuja V
    J Assoc Physicians India; 2002 Jul; 50():979-80. PubMed ID: 12126362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
    Das VN; Ranjan A; Bimal S; Siddique NA; Pandey K; Kumar N; Verma N; Singh VP; Sinha PK; Bhattacharya SK
    Natl Med J India; 2005; 18(3):131-3. PubMed ID: 16130613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New World and Old World Leishmania Infections: A Practical Review.
    Kevric I; Cappel MA; Keeling JH
    Dermatol Clin; 2015 Jul; 33(3):579-93. PubMed ID: 26143433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudanese mucosal leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment.
    el-Hassan AM; Meredith SE; Yagi HI; Khalil EA; Ghalib HW; Abbas K; Zijlstra EE; Kroon CC; Schoone GJ; Ismail A
    Trans R Soc Trop Med Hyg; 1995; 89(6):647-52. PubMed ID: 8594683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of leishmaniasis (Leishmania infantum) in the skin of a patient with severe atopic dermatitis.
    Kerr A; Dawe RS; Nathwani D; Evans AT; Ferguson J
    Br J Dermatol; 2009 Jul; 161(1):202-3. PubMed ID: 19438451
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized, double-blind, comparative clinical trial on the efficacy and safety of intralesional sodium stibogluconate and intralesional 7% hypertonic sodium chloride against cutaneous leishmaniasis caused by L. donovani.
    Ranawaka RR; Weerakoon HS
    J Dermatolog Treat; 2010 Sep; 21(5):286-93. PubMed ID: 20438389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimony-induced cerebellar ataxia.
    Khalil EA; Ahmed AE; Musa AM; Hussein MH
    Saudi Med J; 2006 Jan; 27(1):90-2. PubMed ID: 16432602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
    Lira R; Sundar S; Makharia A; Kenney R; Gam A; Saraiva E; Sacks D
    J Infect Dis; 1999 Aug; 180(2):564-7. PubMed ID: 10395884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problems in the treatment of kala-azar: case report.
    Nyakundi PM; Rashid JR; Wasunna KM; Were JB; Muigai R; Kirigi G; Mbugua J
    East Afr Med J; 1995 Jun; 72(6):406-8. PubMed ID: 7498017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmaniasis.
    Herwaldt BL
    Lancet; 1999 Oct; 354(9185):1191-9. PubMed ID: 10513726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of mucosal leishmaniasis (L. infantum) with miltefosine in a patient with Good syndrome.
    Stoeckle M; Holbro A; Arnold A; Neumayr A; Weisser M; Blum J
    Acta Trop; 2013 Oct; 128(1):168-70. PubMed ID: 23871798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A patient with long-term, unrecognized leishmaniasis].
    Rabelink NM; de Steenwinkel JE; van Biezen P; van Daele PL; Gyssens IC
    Ned Tijdschr Geneeskd; 2006 Dec; 150(49):2715-9. PubMed ID: 17194010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ulcerative post-kala azar mucosal leishmaniasis masquerading as a carcinoma--a case report.
    Toran KC; Sah SP; Joshi A; Rani S
    Indian J Pathol Microbiol; 2003 Jul; 46(3):487-9. PubMed ID: 15025319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
    Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P
    Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Grech P; Vella SM; Piscopo T
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33139372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.